**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
| 2909-52-6 |Bromoform-d | 99 | 220-823-0 |
+----------------+--------------------------------------+----------+-----------+
Text for R-phrases: see Section 16
Hazard Symbols: T N
Risk Phrases: 22 23 36/38 51/53
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful if swallowed. Toxic by inhalation. Irritating to eyes and
skin. Toxic to aquatic organisms, may cause long-term adverse
effects in the aquatic environment.Lachrymator (substance which
increases the flow of tears).
Potential Health Effects
Eye:
Causes eye irritation. Lachrymator (substance which increases the
flow of tears). May cause chemical conjunctivitis.
Skin:
Causes skin irritation. May be absorbed through the skin in harmful
amounts.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. May cause liver and kidney damage. May cause central
nervous system depression. Human fatalities have been reported from
acute poisoning.
Inhalation:
Inhalation of high concentrations may cause central nervous system
effects characterized by nausea, headache, dizziness, unconsciousness
and coma. Causes respiratory tract irritation. May cause liver and
kidney damage. May cause narcotic effects in high concentration.
Inhalation may be fatal as a result of spasm, inflammation, edema of
the larynx and bronchi, chemical pneumonitis and pulmonary edema.
Can produce delayed pulmonary edema.
Chronic:
Repeated exposure may cause central nervous system damage. Effects
may be delayed.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid. Do
NOT allow victim to rub eyes or keep eyes closed.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4
cupfuls of milk or water. Never give anything by mouth to an
unconscious person. Get medical aid.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid. Do NOT use mouth-to-mouth
resuscitation.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Use water
spray to keep fire-exposed containers cool. Use extinguishing media
appropriate to the surrounding fire. Substance is noncombustible.
Vapors may be heavier than air. They can spread along the ground and
collect in low or confined areas. Contact with metals may evolve
flammable hydrogen gas. Containers may explode when heated.
Extinguishing Media:
Substance is noncombustible; use agent most appropriate to
extinguish surrounding fire. Do NOT get water inside containers. For
large fires, use water spray, fog or regular foam. For small fires,
use dry chemical, carbon dioxide, water spray or regular foam. Cool
containers with flooding quantities of water until well after fire
is out.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Avoid runoff into storm sewers and
ditches which lead to waterways. Clean up spills immediately,
observing precautions in the Protective Equipment section. Provide
ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Use with adequate ventilation. Avoid contact with eyes, skin, and
clothing. Keep container tightly closed. Avoid ingestion and
inhalation. Use with adequate ventilation. Wash clothing before
reuse.
Storage:
Store in a tightly closed container. Keep from contact with
oxidizing materials. Store in a cool, dry, well-ventilated area away
from incompatible substances. Keep away from metals. Do not store in
metal containers. Keep away from strong bases.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use process enclosure, local exhaust ventilation, or other
engineering controls to control airborne levels below recommended
exposure limits. Facilities storing or utilizing this material should
be equipped with an eyewash facility and a safety shower.
Exposure Limits
CAS# 75-25-2:
United States OSHA: 0.5 ppm TWA; 5 mg/m3 TWA
Belgium - TWA: 0.5 ppm VLE; 5.3 mg/m3 VLE
France - VME: 0.5 ppm VME; 5 mg/m3 VME
Japan: 1 ppm OEL; 10.3 mg/m3 OEL
Malaysia: 0.5 ppm TWA; 5.2 mg/m3 TWA
Netherlands: 0.5 ppm MAC; 5 mg/m3 MAC
Russia: 5 mg/m3 TWA
Spain: 0.5 ppm VLA-ED; 5.3 mg/m3 VLA-ED
CAS# 2909-52-6:
Personal Protective Equipment
Eyes:
Wear chemical splash goggles.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: clear to yellow
Odor: chloroform-like
pH: Not available.
Vapor Pressure: 4.4 mm Hg @20 C
Viscosity: Not available.
Boiling Point: 136.5 deg C
Freezing/Melting Point: 8 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: 0.1%
Specific Gravity/Density: 2.900
Molecular Formula: CDBr3
Molecular Weight: 253.75
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Metals, excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents, strong acids.
Hazardous Decomposition Products:
Carbon monoxide, irritating and toxic fumes and gases, carbon
dioxide, hydrogen bromide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 75-25-2: PB5600000
CAS# 2909-52-6 unlisted.
LD50/LC50:
CAS# 75-25-2: Inhalation, mouse: LC50 = 12100 mg/m3/2H; Oral, mouse:
LD50 = 1072 mg/kg; Oral, rat: LD50 = 933 mg/kg.
CAS# 2909-52-6.
Carcinogenicity:
Bromoform -
ACGIH: A3 - Confirmed animal carcinogen with unknown relevance to
California: carcinogen, initial date 4/1/91
Bromoform-d -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Other
No information available.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: BROMOFORM
Hazard Class: 6.1
UN Number: 2515
Packing Group: III
IMO
Shipping Name: BROMOFORM
Hazard Class: 6.1
UN Number: 2515
Packing Group: III
RID/ADR
Shipping Name: BROMOFORM
Hazard Class: 6.1
UN Number: 2515
Packing group: III
USA RQ: CAS# 75-25-2: 100 lb final RQ; 45.4 kg final RQ
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T N
Risk Phrases:
R 22 Harmful if swallowed.
R 23 Toxic by inhalation.
R 36/38 Irritating to eyes and skin.
R 51/53 Toxic to aquatic organisms, may cause
long-term adverse effects in the aquatic environment.
Safety Phrases:
S 28 After contact with skin, wash immediately
with...
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 75-25-2: No information available.
CAS# 2909-52-6: No information available.
Canada
CAS# 75-25-2 is listed on Canada's DSL List.
CAS# 75-25-2 is listed on Canada's Ingredient Disclosure List.
CAS# 2909-52-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 75-25-2 is listed on the TSCA inventory.
CAS# 2909-52-6 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
Text for R-phrases from Section 2
MSDS Creation Date: 5/11/1999 Revision #6 Date: 3/04/2004
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Octakis-6-Bromo-6-Deoxy-??5-Cyclodextrin
| 53784-84-2 |
|
Octakis-6-Iodo-6-Deoxy-??5-Cyclodextrin
| 168296-33-1 |
|
4-Chromanol 96%
| 1481-93-2 |
|
Octakis-6-(Dimethyl-Tert-Butylsilyl)-6-Deoxy-??5-Cyclodextrin
| 0-01-1 |
|
Diphenyl phthalate
| 84-62-8 |
|
DL-4-Chlorophenylalanine Methyl Ester Hydrochloride, 99%
| 14173-40-1 |
|
1H-Benzotriazole, 98%
| 95-14-7 |
|
m-Cresol, 95%
| 108-39-4 |
|
Thiodiglycolic Acid,98%
| 123-93-3 |
|
n-Acetyl-s-(2-hydroxyethyl)-l-cysteine
| 15060-26-1 |
|
Methyl 4-(3-Oxo-3-Phenyl-1-Propenyl) Benzoate, 98+% (NMR)
| 98258-72-1 |
|
Barium oxide
| 1304-28-5 |
|
Zinc Sulfide, Pieces, 3-12 mm, 99.9%
| 1314-98-3 |
|
Bromobenzene-d5, 99.5 atom% D
| 4165-57-5 |
|
Toluene-d8, 99.5+ atom % D
| 2037-26-5 |
|
1-Butanol-d10, packaged in ampules, 99+ atom % D
| 71-36-3 |
|
Ethylbenzene-d10, packaged in ampules, 99+ atom% D
| 25837-05-2 |
|
Mesitylene-d12, packaged in ampule, 98 atom% D
| 69441-16-3 |
|
Methylcyclohexane-d14, packaged in ampules, 99 atom % D
| 108-87-2 |
|
Methyl-d3 methacrylate-d5, stabilized
| 80-62-6 |
|
Aniline-d7, 99 atom% D
| 4165-61-1 |
|
Benzyl chloroformate, 50 wt% solution in toluene
| 108-88-3 |
|
Nitrobenzene-D5, 99.5 Atom% D
| 4165-60-0 |
|
1,1,2,2-Tetrachloroethane-d2, 99.5+ atom% D
| 33685-54-0 |
|
4,4'-Ethylenedianiline, 95%
| 621-95-4 |
|
Bromoform-d, stabilized with copper, 99 atom% D
| 75-25-2 |
|
1,2-Bis(dichlorophosphino)ethane, 97%
| 28240-69-9 |
|
N-Benzyl-4-cyano-4-(1-piperidino)-piperidine
| 84254-97-7 |
|
1,3,6,8-Pyrenetetrasulfonic Acid Tetrasodium Salt, 85+% (UV-VIS)
| 59572-10-0 |
|
Dittmer reagent, 95%
| |
|
Isoquinoline, 97%
| 119-65-3 |
|
Alkylbenzene sulfonic acid, mixture of C10-C13 isomers
| |
|
Methyltriallylsilane
| 1112-91-0 |
|
Tetraallylsilane
| 1112-66-9 |
|
2-Ethoxy-2-(2'-phenylsulfonylethyl)-1,3-dioxolane
| 149099-23-0 |
|
Sodium Hydride, Dispersion in Mineral Oil, 75%
| 7646-69-7 |
|
Hexaphenyldisilane
| 1450-23-3 |
|
Citronellal (pract), 93% (gc)
| 106-23-0 |
|
Hydriodic Acid, 57 Wt.% Aq. Solution, Distilled, Unstabilized
| 7732-18-5 |
|
Cyclopentylamine, 99+%
| 1003-03-8 |
|
(Bromomethyl)triphenylphosphonium bromide, 98%
| 1034-49-7 |
|
Methyl trans-3-methoxyacrylate, 95%
| 5788-17-0 |
|
Benzyltriphenylphosphonium borohydride, 98%
| 18117-29-8 |
|
2-Methyl-6-phenylbenzothiazole, 97%
| 107559-02-4 |
|
Ethylenediaminetetraacetic acid ferric sodium salt, trihydrate, 98%
| 15708-41-5 |
|
2,4-Dichlorobenzyl Alcohol, 99%
| 1777-82-8 |
|
Diethyldithiocarbamic Acid Diethylammonium Salt, 98% (Titr.)
| 1518-58-7 |
|
Hydriodic acid, reagent ACS, 55% in water, without stabilizer
| 10034-85-2 |
|
2,2,6,6-Tetramethyl-4-Piperidone Hydrochloride, 97%
| 33973-59-0 |
|
Cellulose Acetate Hydrogen Phthalate, Acetyl Content 17.0-22.0%
| 9004-38-0 |
|
|